Efficient expression of the envelope protein of feline immunodeficiency virus in a recombinant feline herpesvirus type 1 (FHV-1) using the gC promoter of FHV-1

Virus Research

Volumn 70, Issue 1-2, 2000, Pages 13-23

  Sato, Eiji ^a   Yokoyama, Naoaki ^b   Miyazawa, Takayuki ^a   Maeda, Ken ^c   Ikeda, Yasuhiro ^a   Nishimura, Yorihiro ^a   Fujita, Kentaro ^a   Kohmoto, Mariko ^d   Takahashi, Eiji ^a   Mikami, Takeshi ^e  

^a UNIVERSITY OF TOKYO   (Japan)

^b AICHI CANCER CENTER HOSPITAL   (Japan)

^c YAMAGUCHI UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

^e OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

Author keywords

Expression; FHV 1; FIV env gene; Recombinant virus; Vaccine

Indexed keywords

SIGNAL PEPTIDE; THYMIDINE KINASE; VIRUS ENVELOPE PROTEIN; VIRUS VACCINE;

ANIMAL CELL; ARTICLE; CAT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXPRESSION VECTOR; FELINE IMMUNODEFICIENCY VIRUS; FLOW CYTOMETRY; GENE CASSETTE; GENE FUSION; HERPES SIMPLEX VIRUS 1; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; KIDNEY CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; VIROGENESIS; VIRUS RECOMBINANT;

ANIMALS; ANTIGENS, VIRAL; BLOTTING, SOUTHERN; CATS; CELLS, CULTURED; GENES, VIRAL; GENETIC VECTORS; IMMUNOBLOTTING; IMMUNODEFICIENCY VIRUS, FELINE; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; VARICELLOVIRUS; VIRAL ENVELOPE PROTEINS;

EID: 0033764767     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(00)00202-1     Document Type: Article

References (31)

1. Development, characterization, and viral susceptibility of a feline (felis catus) renal cell line (CRFK)
2. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination
3. Functional analysis of regulatory regions controlling strict late HSV gene expression
4. Feline herpesvirus type 1 glycoproteins eliciting virus neutralizing and hemagglutination-inhibiting antibodies
5. Suppression of virus burden by immunization with feline immunodeficiency virus Env protein
6. Identification of feline immunodeficiency virus rev gene activity
7. Partial protection by vaccination with recombinant feline immunodeficiency virus surface glycoproteins
8. Identification and characterization of the feline herpesvirus type 1 glycoprotein C gene
9. Molecular characterization and heterogeneity of feline immunodeficiency virus isolates
10. The HIV-1 rev-trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA
11. Biological nature of feline immunodeficiency virus
12. Establishment of a feline T-lymphoblastoid cell line highly sensitive for replication of feline immunodeficiency virus
13. Studies on cytopathogenic viruses from cats with respiratory infections. III. Isolation and certain properties of feline herpesviruses
14. Characterization of promoters integrated in the genome of bovine herpesvirus-1 (BHV-1)
15. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome
16. Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus
17. A review of feline viral rhinotracheitis (feline herpesvirus I infection)
18. Intragenic cis-acting art gene-responsive sequence of the human immunodeficiency virus
19. Physical characterization of the genome of feline herpesvirus-1
20. Construction of a recombinant feline herpesvirus type 1 expressing Gag precursor protein of feline immunodeficiency virus
21. A feline herpesvirus-1 recombinant with a deletion in the genes for glycoproteins gI and gE is effective as a vaccine for feline rhinotracheitis
22. FIV infection of the domestic cat: An animal model for AIDS
23. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats
24. Experimental vaccine protection against feline immunodeficiency virus
25. Experimental vaccine protection against homologous and heterologous strains of feline immunodeficiency virus
26. Construction of the recombinant feline herpesvirus type 1 deleted thymidine kinase gene
27. Pathogenicity and vaccine efficacy of a thymidine kinase-deficient mutant of feline herpesvirus type 1 in cats
28. Vaccine efficacy of recombinant feline herpesvirus type 1 expressing immunogenic proteins of feline calicivirus in cats
29. Recombinant feline herpesvirus type 1 expressing immunogenic proteins inducible virus neutralizing antibody against feline calicivirus in cats
30. Recombinant viral vector vaccines for the veterinary use
31. Further development of a recombinant feline herpesvirus type 1 vector expressing feline calicivirus immunogenic antigen